BIO-TECHNE Corp Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.90M, a 15.35% decline year-over-year.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $2.01M, a 9.65% decline year-over-year.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $2.24M, a 0.49% decline year-over-year.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $2.23M, a 6.35% increase year-over-year.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for fiscal 2026 was $3.91M, a 12.53% decline from fiscal 2025.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for fiscal 2025 was $4.47M, a 2.88% increase from fiscal 2024.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for fiscal 2024 was $4.34M, a 11.43% decline from fiscal 2023.
- BIO-TECHNE Corp stock issued during period, value, employee stock purchase plan for fiscal 2023 was $4.91M, a 82.11% increase from fiscal 2022.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $3.91M 10-K · filed 2026-08-24 | |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-06 | |
| 2025-09-30 | $2.01M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $4.47M 10-K · filed 2026-08-24 | |
| 2025-03-31 | $2.24M 10-Q · filed 2026-05-06 | |
| 2024-09-30 | $2.23M 10-Q · filed 2026-05-06 | |
| 2024-06-30 | $4.34M 10-K · filed 2026-08-24 | |
| 2024-03-31 | $2.25M 10-Q · filed 2025-05-08 | |
| 2023-09-30 | $2.09M 10-Q · filed 2025-05-08 | |
| 2023-06-30 | $4.91M 10-K · filed 2025-08-22 | |
| 2023-03-31 | $2.39M 10-Q · filed 2024-05-06 | |
| 2022-09-30 | $2.52M 10-Q · filed 2024-05-06 | |
| 2022-06-30 | $2.69M 10-K · filed 2024-08-22 | |
| 2022-03-31 | $1.33M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $6.00K 10-Q · filed 2023-05-08 | |
| 2021-09-30 | $1.36M 10-Q · filed 2023-05-08 | |
| 2021-06-30 | $2.79M 10-K · filed 2023-08-23 | |
| 2021-03-31 | $1.33M 10-Q · filed 2022-05-09 | |
| 2020-09-30 | $1.46M 10-Q · filed 2022-05-09 | |
| 2020-06-30 | $2.31M 10-K · filed 2022-08-24 | |
| 2020-03-31 | $1.22M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-08 | |
| 2019-09-30 | $1.10M 10-Q · filed 2021-05-07 | |
| 2019-06-30 | $1.68M 10-K · filed 2021-08-25 | |
| 2019-03-31 | $834.00K 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $0.00 10-Q · filed 2020-05-11 | |
| 2018-09-30 | $842.00K 10-Q · filed 2020-05-11 | |
| 2018-06-30 | $1.51M 10-K · filed 2020-08-26 | |
| 2018-03-31 | $752.00K 10-Q · filed 2019-05-07 | |
| 2017-09-30 | $755.00K 10-Q · filed 2019-05-07 | |
| 2017-06-30 | $1.02M 10-K/A · filed 2019-11-06 | |
| 2016-06-30 | $692.00K 10-K · filed 2018-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |